A new study classifies frailty in older people, coming up with two subtypes. The classification may further help clinicians ...

Patients with CLL and a CSHA CFS score greater than 3 had significantly higher rates of treatment interruption due to adverse effects.

The Fracture Risk Assessment Tool (FRAX), widely used for predicting the 10-year likelihood of hip fractures, does not incorporate factors like prior falls and sociodemographic characteristics, ...

The platform ensures a seamless transition from clinical development to commercial-scale manufacturing, eliminating the need for costly process redesigns and multiple technology transfers and ...

A new study has identified significant biases in medical recommendations from large language models (LLMs), validating some physicians' concerns about AI's clinical capabilities. Researchers at ...

By adopting modular architectures and cost-aware practices, teams can efficiently scale up or down, shedding low-value components when needed. This approach ensures resilience and aligns technical ...

In this Pharmaceutical Executive video interview, LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses strategies to address underrepresentation in clinical trials, ...

Published in the journal Nature Ecology and Evolution, their results show major barriers to effective interventions include the small scale of restoration programs, high costs per hectare ...

According to a Reuters report, a focus of the talks will be how to address regulatory hurdles that have contributed to a decline in clinical trial activity within Europe. The meeting comes amid ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.